Citation: Wm. Williams et Da. Isenberg, NATURALLY-OCCURRING ANTIIDIOTYPIC ANTIBODIES REACTIVE WITH ANTI-DNA ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Lupus, 7(3), 1998, pp. 164-175
Authors:
STEPHANOU A
CONROY S
ISENBERG DA
MAIONE D
POLI V
CILIBERTO G
LATCHMAN DS
Citation: A. Stephanou et al., ELEVATION OF IL-6 IN TRANSGENIC MICE RESULTS IN INCREASED LEVELS OF THE 90 KDA HEAT-SHOCK-PROTEIN (HSP90) AND THE PRODUCTION OF ANTI-HSP90 ANTIBODIES, Journal of autoimmunity (Print), 11(3), 1998, pp. 249-253
Citation: N. Sutcliffe et al., FUNCTIONAL DISABILITY AND END-ORGAN DAMAGE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), SLE AND SJOGRENS-SYNDROME (SS), AND PRIMARYSS, Journal of rheumatology, 25(1), 1998, pp. 63-68
Authors:
STEPHANOU A
ISENBERG DA
AKIRA S
KISHIMOTO T
LATCHMAN DS
Citation: A. Stephanou et al., THE NUCLEAR FACTOR INTERLEUKIN-6 (NF-IL6) AND SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION-3 (STAT-3) SIGNALING PATHWAYS COOPERATE TO MEDIATE THE ACTIVATION OF THE HSP90-BETA GENE BY INTERLEUKIN-6 BUT HAVEOPPOSITE EFFECTS AN ITS INDUCIBILITY BY HEAT-SHOCK, Biochemical journal, 330, 1998, pp. 189-195
Citation: Mr. Cohen et al., EROSIVE ARTHRITIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - ANALYSIS OF A DISTINCT CLINICAL AND SEROLOGICAL SUBSET, British journal of rheumatology, 37(4), 1998, pp. 421-424
Authors:
INANC M
DONOHOE S
RAVIRAJAN CT
RADWAYBRIGHT EL
MACKIE I
MACHIN S
ISENBERG DA
Citation: M. Inanc et al., ANTI-BETA-2-GLYCOPROTEIN-I, ANTI-PROTHROMBIN AND ANTICARDIOLIPIN ANTIBODIES IN A LONGITUDINAL-STUDY OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND THE ANTIPHOSPHOLIPID SYNDROME, British journal of rheumatology (Print), 37(10), 1998, pp. 1089-1094
Citation: A. Rahman et al., THE ROLE OF IN-VITRO EXPRESSION SYSTEMS IN THE INVESTIGATION OF ANTIBODIES TO DNA, Seminars in arthritis and rheumatism, 28(2), 1998, pp. 130-139
Citation: Aj. Hakim et al., AUTOIMMUNE THROMBOCYTOPENIA IN PRIMARY ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS-ERYTHEMATOSUS - THE RESPONSE TO SPLENECTOMY, Seminars in arthritis and rheumatism, 28(1), 1998, pp. 20-25
Authors:
RAVIRAJAN CT
RAHMAN MA
PAPADAKI L
GRIFFITHS MH
KALSI J
MARTIN ACR
EHRENSTEIN MR
LATCHMAN DS
ISENBERG DA
Citation: Ct. Ravirajan et al., GENETIC, STRUCTURAL AND FUNCTIONAL-PROPERTIES OF AN IGG DNA-BINDING MONOCLONAL-ANTIBODY FROM A LUPUS PATIENT WITH NEPHRITIS, European Journal of Immunology, 28(1), 1998, pp. 339-350
Authors:
MOCKRIDGE CI
CHAPMAN CJ
SPELLERBERG MB
SHETH B
FLEMING TP
ISENBERG DA
STEVENSON FK
Citation: Ci. Mockridge et al., SEQUENCE-ANALYSIS OF V4-34-ENCODED ANTIBODIES FROM SINGLE B-CELLS OF 2 PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Clinical and experimental immunology, 114(1), 1998, pp. 129-136
Authors:
BOURNE T
ZUKOWSKACOOPER M
SALAMAN MR
SEIFERT MH
ISENBERG DA
Citation: T. Bourne et al., SPONTANEOUS IMMUNOGLOBULIN-PRODUCING CAPACITY OF CULTURES FROM LUPUS PATIENTS AND NORMAL DONORS FOLLOWING DEPLETION OF CELLS EXPRESSING CD19 OR CD38, Clinical and experimental immunology, 111(3), 1998, pp. 611-616
Authors:
KUMAR B
KALSI J
RAHMAN A
PEARL L
ISENBERG DA
Citation: B. Kumar et al., EXPRESSION OF THE FABS OF ANTI-HUMAN DS DNA ANTIBODY B3 IN ESCHERICHIA-COLI, Arthritis and rheumatism, 41(9), 1998, pp. 220-220
Authors:
ANAND A
QURESHI AC
ISENBERG DA
LYDYARD PM
Citation: A. Anand et al., CHARACTERIZATION OF DOUBLE-NEGATIVE T-CELLS IN PATIENTS WITH SYSTEMICLUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(9), 1998, pp. 250-250
Citation: Cm. Tench et Da. Isenberg, THE VARIATION IN ANTI-ENA PROFILE BETWEEN DIFFERENT ETHNIC POPULATIONS WITH SLE OVER A 10-YEAR PERIOD, Arthritis and rheumatism, 41(9), 1998, pp. 437-437
Authors:
MOORE A
PETRI MA
MANZI S
ISENBERG DA
GORDON C
SENECAL JL
STPIERRE Y
FORTIN PR
SUTCLIFFE N
GOUTET JR
CHOQUETTE D
GRODZICKY T
ESDAILE JM
CLARKE AE
Citation: A. Moore et al., THE USE OF ALTERNATIVE MEDICAL THERAPIES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 41(9), 1998, pp. 605-605
Authors:
PITTONI V
RAVIRAFAN CT
DONOHOE S
MACHIN SJ
MACKIE IJ
LVDVARD PM
ISENBERG DA
Citation: V. Pittoni et al., HUMAN MONOCLONAL ANTIPHOSPHOLIPID ANTIBODIES BIND TO MEMBRANE PHOSPHOLIPID AND A CRYPTIC EPITOPE OF BETA-2-GLYCOPROTEIN-1 ON APOPTOTIC CELLS, Arthritis and rheumatism, 41(9), 1998, pp. 802-802
Citation: Ct. Raviraian et al., EFFECT OF ANTI-IL10 AND ANTI-C5 ON HUMAN ANTI-DS DNA ANTIBODY-INDUCEDKIDNEY DAMAGE, Arthritis and rheumatism, 41(9), 1998, pp. 865-865
Authors:
SUTCLIFFE N
GORDON C
CLERKE AE
FAREWELL V
ISENBERG DA
Citation: N. Sutcliffe et al., THE ASSOCIATION OF SOCIOECONOMIC-STATUS, RACE, PSYCHOSOCIAL FACTORS AND OUTCOMES IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 41(9), 1998, pp. 1122-1122
Authors:
STPIERRE Y
PENROD J
PETRI M
MANZI S
ISENBERG DA
GORDON C
SENECAL JL
JOSEPH L
FORTIN PR
SUTCLIFFE N
GOULET JR
CHOQUETTE D
GRODZICKY T
ESDAILE JM
CLARKE AE
Citation: Y. Stpierre et al., UNDERESTIMATING THE VALUE OF RHEUMATIC DISEASES - ASSESSING THE INDIRECT COSTS OF WOMEN WITH LUPUS (SLE), Arthritis and rheumatism, 41(9), 1998, pp. 1131-1131
Authors:
CLARKE AE
PETRI M
MANZI S
ISENBERG DA
GORDON C
SENECAL JL
STPIERRE Y
JOSEPH L
PENROD J
FORTIN PR
SUTCLIFFE N
GOULET JR
CHOQUETTE D
GRODZICKY T
ESDAILE JM
Citation: Ae. Clarke et al., AN INTERNATIONAL COMPARISON OF HEALTH COSTS AND CHANGE IN HEALTH-STATUS (HS) IN SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1143-1143
Authors:
CLARKE AE
PETRI M
MANZI S
ISENBERG DA
GORDON C
SENECAL JL
STPIERRE Y
JOSEPH L
PENROD J
FORTIN PR
SUTCLIFFE N
GOULET JR
CHOQUETTE D
GRODZICKY T
ESDAILE JM
Citation: Ae. Clarke et al., PREDICTING HEALTH-CARE UTILIZATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - COUNTRY OF CARE, DISEASE DAMAGE AND HEALTH-STATUS, Arthritis and rheumatism, 41(9), 1998, pp. 1144-1144
Citation: El. Radwaybright et al., THE PREVALENCE OF ANTIBODIES TO ANIONIC PHOSPHOLIPIDS IN PATIENTS WITH THE PRIMARY ANTIPHOSPHOLIPID SYNDROME (PAPS), SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) AND THEIR RELATIVES SPOUSES/, Arthritis and rheumatism, 41(9), 1998, pp. 1251-1251
Authors:
DECKER P
BRIAND JP
DEMURCIA G
PERO RW
ISENBERG DA
MULLER S
Citation: P. Decker et al., ZINC IS AN ESSENTIAL COFACTOR FOR RECOGNITION OF THE DNA-BINDING DOMAIN OF POLY(ADP-RIBOSE) POLYMERASE BY ANTIBODIES IN AUTOIMMUNE RHEUMATIC AND BOWEL DISEASES, Arthritis and rheumatism, 41(5), 1998, pp. 918-926